直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Workshop

Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law

July 18, 2019

Palo Alto, CA

This workshop addresses a diverse set of issues that are relevant to life sciences patent practitioners in protecting their own company’s products and patent portfolios and evaluating the portfolios of others. Specifically, we will offer the following presentations in this workshop:

  • Recent Developments Surrounding Standing, FDA Guidance on Interchangeability for Biologics, and Section 101 Subject Matter Eligibility in the Life Sciences
  • Patent Strategies for Inventions in the Life Sciences
  • Antibody Patenting
  • What Do Recent Cases Teach Us About Meeting the Written Description Requirement for Life Sciences and Biotechnology Inventions?
  • IP and Regulatory Considerations Regarding Cell Therapy

Speakers:
Paul Barker
Marta Garcia Daneshvar
Barbara Rudolph
Linda Wadler

Who Should Attend: General counsel and in-house patent counsel with responsibility for/interest in protecting a company’s intellectual property.

Date:
Thursday, July 18, 2019

Time:
12:30 - 5:30 p.m.

Location:
Palo Alto, CA

How to Register: To attend, please register online by Tuesday, July 16.

MCLE Credit: Finnegan confirms that this activity has been certified for 3.25 hours of California MCLE.

For questions or information on attending, please let us know.

Tags

antibodies, subject matter eligibility

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Prosecution and Portfolio Management

Patent Drafting and Prosecution

Related Industries

Life Sciences

Pharmaceutical

Biotechnology

Biologics

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Conference

31st Annual UMass Chan Research Retreat

October 14-15, 2026

Worcester

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Webinar

U.S. Patent Case Law Update 2026

July 23, 2026

Webinar

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP